HMS
ALLO icon

Hanseatic Management Services’s Allogene Therapeutics ALLO Stock Holding History

Hanseatic Management Services’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39,340
Closed -$425K – 108
2022
Q3 		$425K Buy
+39,340
New +$535K 1.15% 31

Other funds holding ALLO

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hanseatic Management Services's ALLO Position: Q4 2022 in Review

Hanseatic Management Services sold out of Allogene Therapeutics (ALLO) in Q4 2022, closing a stake of 39,340 shares — an estimated $425K sold.

Hanseatic Management Services first reported a position in ALLO in Q3 2022 and held it in 1 quarter. The position peaked at $425K in Q3 2022. 168 funds tracked by Wall St. Rank hold ALLO as of Q4 2022.

  • Hanseatic Management Services reported no remaining Allogene Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Hanseatic Management Services sold 39,340 Allogene Therapeutics shares in Q4 2022, an estimated $425K.
  • Hanseatic Management Services first reported a position in Allogene Therapeutics in Q3 2022 and held it in 1 quarter.
  • Hanseatic Management Services's Allogene Therapeutics position peaked at $425K in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q4 2022.

Based on Hanseatic Management Services's 13F filing for Q4 2022, filed 26 Jan 2023.